Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
InChiKey: ODKNJVUHOIMIIZ-RRKCRQDMSA-N
3 hours after MCAO) at the time of ischemia onset also dose-dependently reduced infarct size
PMCID: PMC6289123
Formula: C20H23NO3S
It was developed in Spain by FAES Farma
TAK-659 3992 InChiKey: ODKNJVUHOIMIIZ-RRKCRQDMSA-NTAK 659 is a highly potent, selective, reversible and orally available dual inhibitor of spleen tyrosine kinase (SYK) and fms related tyrosine kinase 3 (FLT3), with an IC50 of 3. 2 nM and 4. 6 nM for SYK and FLT3, respectively. TAK 659 induces cell death in tumor cells but not in nontumor cells, and with potential for the treatment of chronic lymphocytic leukemia (CLL). Product information CAS Number: 1312691 33 0 Molecular Weight: 344. 39 Formula:
US$ 178.95
US$ 10.71
US$ 139.95